Julie Rubinstein sold $954K of ADPT stock

Julie Rubinstein, President and COO of Adaptive Biotechnologies Corp (ADPT), sold 35,643 shares of ADPT stock worth $954K, per an SEC Form 4 filed Nov 7, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Nov 4, 2026, 3 days before it was made public.

ADPT has moved +4.8% since the trade date, from $26.71 to $27.98 (Nov 6, 2026 close).